Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Effectiviteit en immunogeniciteit van het R21/Matrix-M-vaccin: 2 jaar follow-up
feb 2023 | Parasitaire infecties